SCHEMBL6134697

SCHEMBL6134697

CCCCOC1CCN(c2ccc(-c3nnc(-c4ccc(C(=O)OC)cc4)s3)cc2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 4/20 0.43
CSNK2A1 P68400 4/20 0.43
ALDH1A1 P00352 3/20 0.41
DDX3X O00571 1/20 0.41
GRM2 Q14416 1/20 0.40
USP2 O75604 1/20 0.40
HPGD P15428 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HRH3 Q9Y5N1 1/20 0.40
PDE4D Q08499 1/20 0.39
PDE7A Q13946 1/20 0.39
MAPT P10636 4/20 0.38
XIAP P98170 1/20 0.38
TSHR P16473 1/20 0.38
TAAR1 Q96RJ0 1/20 0.38
HSD17B10 Q99714 1/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
KMT2A Q03164 2/20 0.38
CASP1 P29466 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6135356 0.97 CSNK2A2 (0.44) CSNK2A2CSNK2A1ALDH1A1DDX3XGRM2
SCHEMBL6132272 0.91 ALDH1A1 (0.41) CSNK2A2CSNK2A1ALDH1A1GRM2USP2
SCHEMBL6934067 0.91 ALDH1A1 (0.41) CSNK2A2CSNK2A1ALDH1A1GRM2USP2
SCHEMBL6132291 0.91 ALDH1A1 (0.41) CSNK2A2CSNK2A1ALDH1A1GRM2USP2
SCHEMBL6135503 0.90 CSNK2A2 (0.52) CSNK2A2CSNK2A1USP2HRH3RARB
SCHEMBL6135070 0.90 ALDH1A1 (0.39) CSNK2A2CSNK2A1ALDH1A1GRM2USP2
SCHEMBL6134390 0.87 CSNK2A2 (0.53) CSNK2A2CSNK2A1USP2TSHRRARB
SCHEMBL6134811 0.86 ALDH1A1 (0.38) CSNK2A2CSNK2A1ALDH1A1GRM2USP2
SCHEMBL6135390 0.83 PDE4D (0.45) ALDH1A1USP2HRH3PDE4DPDE7A
SCHEMBL6133632 0.83 HDAC3 (0.48) ALDH1A1GRM2HPGDSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050261177-A1 Compound ASTELLAS PHARMA INC. (JP) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261177-A1 Compound MANBA, MAN2B1, MAN2A1 CSNK2A2 1527/4885CSNK2A1 961/4885ALDH1A1 3841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.